IOL Chemicals And Pharmaceuticals Share Price
200.87+4.44 (+2.26%)
+98.19% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 2% | 12% |
| - | - | 0% | 36% |
| 21% | 12% | 32% | 94% |
| 9% | 9% | 8% | 8% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
IOLCP
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,901.4 | ₹456833 Cr | 37.77 | 12.07 | 62.82 | ₹11479 Cr |
| 9,180.5 | ₹245426 Cr | 83.91 | 34.04 | 128.41 | ₹2568 Cr |
| 4,860.5 | ₹187320 Cr | 85.89 | 16.72 | 97.06 | ₹2163 Cr |
| 1,131 | ₹113217 Cr | 25.09 | 9.42 | 62.53 | ₹5040 Cr |
| 1,382.9 | ₹112212 Cr | 33.29 | 9.77 | 57.87 | ₹3879 Cr |
| 1,851.3 | ₹101155 Cr | 92.52 | 6.8 | 29.25 | ₹889 Cr |
| 2,123.2 | ₹97626 Cr | 17.66 | 30.95 | 154.36 | ₹5333 Cr |
| 2,336.5 | ₹96859 Cr | 47.42 | 13.75 | 71.08 | ₹1913 Cr |
| 1,162.4 | ₹96406 Cr | 29.92 | 5.32 | 63.99 | ₹4196 Cr |
| 1,658 | ₹93614 Cr | 25.22 | 17.95 | 96.84 | ₹3505 Cr |
| 200.87 | ₹5753 Cr | 34.22 | 2.19 | 8.51 | ₹138 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹756 Cr | ₹619 Cr | ₹580 Cr | ₹568 Cr | ₹552 Cr | ₹528 Cr | ₹523 Cr | ₹526 Cr | ₹502 Cr | ₹504 Cr | ₹520 Cr | ₹545 Cr | ₹563 Cr | ₹587 Cr | ₹523 Cr | ₹541 Cr | ₹565 Cr | ₹572 Cr |
| ₹8 Cr | ₹2 Cr | ₹5 Cr | ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹7 Cr |
| ₹764 Cr | ₹621 Cr | ₹586 Cr | ₹574 Cr | ₹559 Cr | ₹532 Cr | ₹527 Cr | ₹532 Cr | ₹510 Cr | ₹511 Cr | ₹529 Cr | ₹552 Cr | ₹570 Cr | ₹596 Cr | ₹530 Cr | ₹546 Cr | ₹570 Cr | ₹579 Cr |
| ₹674 Cr | ₹547 Cr | ₹543 Cr | ₹530 Cr | ₹509 Cr | ₹484 Cr | ₹495 Cr | ₹502 Cr | ₹468 Cr | ₹471 Cr | ₹492 Cr | ₹497 Cr | ₹505 Cr | ₹504 Cr | ₹493 Cr | ₹521 Cr | ₹520 Cr | ₹538 Cr |
| ₹112 Cr | ₹94 Cr | ₹63 Cr | ₹64 Cr | ₹70 Cr | ₹67 Cr | ₹51 Cr | ₹48 Cr | ₹58 Cr | ₹57 Cr | ₹53 Cr | ₹71 Cr | ₹80 Cr | ₹104 Cr | ₹49 Cr | ₹37 Cr | ₹61 Cr | ₹52 Cr |
| ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr |
| ₹87 Cr | ₹71 Cr | ₹28 Cr | ₹40 Cr | ₹46 Cr | ₹45 Cr | ₹28 Cr | ₹26 Cr | ₹40 Cr | ₹37 Cr | ₹32 Cr | ₹51 Cr | ₹61 Cr | ₹87 Cr | ₹33 Cr | ₹22 Cr | ₹47 Cr | ₹39 Cr |
| ₹64 Cr | ₹53 Cr | ₹21 Cr | ₹30 Cr | ₹34 Cr | ₹31 Cr | ₹21 Cr | ₹19 Cr | ₹30 Cr | ₹28 Cr | ₹23 Cr | ₹38 Cr | ₹46 Cr | ₹65 Cr | ₹24 Cr | ₹16 Cr | ₹35 Cr | ₹30 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
| ₹1740 Cr | ₹1629 Cr | ₹1553 Cr | ₹1449 Cr | ₹1334 Cr |
| ₹1740 Cr | ₹1629 Cr | ₹1553 Cr | ₹1449 Cr | ₹1334 Cr |
| ₹1799 Cr | ₹1688 Cr | ₹1612 Cr | ₹1508 Cr | ₹1392 Cr |
| ₹85 Cr | ₹78 Cr | ₹66 Cr | ₹56 Cr | ₹53 Cr |
| ₹2 Cr | ₹0 | ₹4 L | ₹14 L | ₹43 L |
| ₹11 Cr | ₹7 Cr | ₹7 Cr | ₹2 Cr | ₹3 Cr |
| ₹98 Cr | ₹85 Cr | ₹73 Cr | ₹58 Cr | ₹57 Cr |
| — | — | — | — | — |
| ₹483 Cr | ₹428 Cr | ₹469 Cr | ₹314 Cr | ₹409 Cr |
| ₹70 Cr | ₹63 Cr | ₹55 Cr | ₹54 Cr | ₹54 Cr |
| ₹132 Cr | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
| ₹49 Cr | ₹31 Cr | ₹40 Cr | ₹54 Cr | ₹69 Cr |
| ₹733 Cr | ₹639 Cr | ₹597 Cr | ₹503 Cr | ₹575 Cr |
| ₹2630 Cr | ₹2411 Cr | ₹2282 Cr | ₹2068 Cr | ₹2024 Cr |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹18 L |
| ₹132 Cr | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
| — | — | — | — | — |
| ₹1632 Cr | ₹1544 Cr | ₹1236 Cr | ₹995 Cr | ₹762 Cr |
| ₹451 Cr | ₹374 Cr | ₹303 Cr | ₹243 Cr | ₹201 Cr |
| ₹1182 Cr | ₹1171 Cr | ₹933 Cr | ₹752 Cr | ₹561 Cr |
| ₹94 Cr | ₹21 Cr | ₹100 Cr | ₹81 Cr | ₹102 Cr |
| ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹0 |
| ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹0 |
| ₹20 Cr | ₹12 Cr | ₹24 Cr | ₹10 Cr | ₹11 Cr |
| ₹45 Cr | ₹9 Cr | ₹50 Cr | ₹233 Cr | ₹205 Cr |
| ₹1359 Cr | ₹1231 Cr | ₹1125 Cr | ₹1102 Cr | ₹881 Cr |
| — | — | — | — | — |
| ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| ₹371 Cr | ₹361 Cr | ₹425 Cr | ₹326 Cr | ₹410 Cr |
| ₹603 Cr | ₹514 Cr | ₹471 Cr | ₹505 Cr | ₹470 Cr |
| ₹198 Cr | ₹208 Cr | ₹143 Cr | ₹22 Cr | ₹140 Cr |
| ₹30 Cr | ₹27 Cr | ₹25 Cr | ₹30 Cr | ₹31 Cr |
| ₹65 Cr | ₹67 Cr | ₹90 Cr | ₹82 Cr | ₹90 Cr |
| ₹1271 Cr | ₹1180 Cr | ₹1157 Cr | ₹967 Cr | ₹1143 Cr |
| ₹537 Cr | ₹541 Cr | ₹560 Cr | ₹464 Cr | ₹567 Cr |
| ₹2630 Cr | ₹2411 Cr | ₹2282 Cr | ₹2068 Cr | ₹2024 Cr |
| ₹61 | ₹57 | ₹274 | ₹257 | ₹237 |
| ₹61 | ₹57 | ₹55 | ₹257 | ₹237 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| ₹184 Cr | ₹138 Cr | ₹182 Cr | ₹189 Cr | ₹225 Cr |
| ₹85 Cr | ₹80 Cr | ₹60 Cr | ₹44 Cr | ₹33 Cr |
| -₹17 Cr | -₹21 Cr | ₹90 Cr | -₹64 Cr | -₹102 Cr |
| ₹252 Cr | ₹197 Cr | ₹332 Cr | ₹169 Cr | ₹156 Cr |
| ₹214 Cr | ₹179 Cr | ₹290 Cr | ₹122 Cr | ₹93 Cr |
| -₹198 Cr | -₹154 Cr | -₹191 Cr | -₹120 Cr | -₹121 Cr |
| -₹29 Cr | ₹46 Cr | -₹93 Cr | -₹4 Cr | -₹2 Cr |
| -₹13 Cr | ₹70 Cr | ₹6 Cr | -₹2 Cr | -₹29 Cr |
| ₹78 Cr | ₹8 Cr | ₹1 Cr | ₹3 Cr | ₹32 Cr |
| ₹65 Cr | ₹78 Cr | ₹8 Cr | ₹1 Cr | ₹3 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found